The Israel Biomedical Technologies: BIO-TECH ISRAEL 2005 - CONFERENCE AND EXHIBITION [Tel Aviv, Israel, May 24-26, 2005]

PROGRAM

Tuesday,
May 24, 2005

Wednesday,
May 25, 2005

Thursday,
May 26, 2005

WEDNESDAY, MAY 25, 2005

09:00 - 10:00

Morning Plenary Session

Plenary Hall

Chairperson: Prof. Haim Aviv
Pharmos Ltd. Israel

09:00 - 09:20

Prof. Ray Hill
Merck Sharpe & Dohme,UK
Big Pharma-Biotech A Model For Cooperation

09:20 - 10:00

Keynote Speaker: Dr. Jonathan Trent
NASA, USA
The Bio-Nano-Technology Interface: A Look Into The Future

10:00 - 11:30

The Respiratory & Inflammatory Diseases Session

Plenary Hall

10:00 - 10:30

Prof. Warren Zapol
Massachusetts General Hospital, USA
Inhaled Nitric Oxide: From Bench To Rescuing Blue Babies

10:30 - 11:00

Prof. Nabil Hanna
InVision Biotherapy, USA
Shifting Paradigms and Future Trends in Therapy of Rheumatoid Arthritis

11:00 - 11:30

Prof. Irun Cohen
The Weizmann Institute, Israel
Inflammatory Feed-Back Mechanisms

COFFEE BREAK

12:00 - 13:15

Respiratory & Inflammatory Diseases Session - Company Presentations - Parallel Sessions

HALL A	HALL B	HALL C
Session Chairperson Prof. Y. Weiss	Session Chairperson Mrs. R. Alon	Session Chairperson Mr. A. Reiter
P. Assaf RENOPHARM LTD New Breakthrough in the Treatment of Inflammatory Bowel Diseases (Ibd)	Y. Cohen MORRIA BIOPHARMACEUTICALS Mfaids: A Novel Multi-Functional Approach to the Treatment of Inflammatory/Allergic Diseases from Morria Biopharmaceuticals	Y. Porat THERAVITAE LTD Blood-Bourne Autologous Endothelial Progenitor Cells as a Potential Treatment for Severe Angina Pectoris
E. Be’eri ALYN HOSPITAL A Noninvasive Method for Maintaining Clear Airways In ICU Ventilated Patients	L. Hayardeny INNOVATIVE R&D, TEVA Oleyl Alcohol Derivative as a Potential Treatment for Psoriasis.New Project In Research Stage At Teva	P. Fishman CAN-FITE BIOPHARMA The A3 Adenosine Receptor as a Novel Target to Combat Autoimmune Inflammatory Diseases
D. Mevorach HADASSAH-HEBREW UNIVERSITY Tolaren: Using the Physiological Way to Maintain Tolerance	Y. Feld GENEGRAFTS LTD Excitable Tissue Modification by Genetically Modified Cell Grafts Overexpressing Ion Channels	Y. Naparstek VERTOMEDICAL LTD Specific Immunoadsorption of Pathogenic Antibodies for the Treatment Of Sle
I. Kushnir DEEPBREEZE Vibration Response Imaging	D. Harats VASCULAR BIOGENICS LTD Vascular Biogenics Ltd. - The Development of New Anti Inflammatory Agents	I. Ostfeld BIOXIM A New Approach or Reducing Catheter Associated Nosocomial Infections
	S. Berliner TEL AVIV SOURASKY MEDICAL CENTRE Online Controlling of Microinflammation	E.Fireman TEL AVIV SOURASKY MEDICAL CENTER The use of Particle Size Distribution (PSD) In Induced Sputum (IS) In The Management Of Lung Diseases

13:00-14:00

LUNCH BREAK

14:00 - 15:30

Afternoon Plenary Session

Plenary Hall

Chairperson: Mr. Jeff Wiesen
Mintz Levin, USA

14:00 - 14:30

Mr. Fred Frank
Lehman Brothers, USA
Life Science-The Financial Perspective

14:30 - 15:00

Dr. Murray Lumpkin
FDA, USA
The Role of Regulatory Authorities in Enhancing Medical Science Innovation

15:00 - 15:30

Mr. Mark Levin
Millennium Pharmaceuticals, USA
Challenges Driving Opportunity: Convergence

15:30 - 16:00

COFFEE BREAK

16:00-17:30

Panel-Convergence as Engine for Progress

Plenary Hall

Moderator: Mr. Martin Gerstel
Compugen Ltd. Israel
Panelists:
Dr. Graig Marshall
GE Healthcare Ltd, UK
Dr. Yoav Medan
Insightec, Israel
Mr.Gavriel D. Meron
Given Imaging, Israel
Dr. Theodore Torphy
Johnson&Johnson, USA

17:30-18:00

Itay Talgam
“Winning through the gaps”-a special presentation for Biotech 2005 by leading Israeli conductor

18:00 -19:30

Cocktail Reception

Host: Dr. Rafi Hofstein
ILSI Organisation, Israel
Greetings
Mr. Ehud Olmert
Vice Prime Minister & Minister ofIndustry, Trade and Labor
Mr. Martin Gerstel
Chairman, Compugen Ltd.
Mr. Raanan Dinor
CEO Ministry of Industry, Trade and Labor
Dr. Jonathan D. Reis
PureTech, USA
Mr. Dov Hershberg
BIRD Foundation, Israel

RECEPTION HIGHLIGHTS

Rad Biomed Award